M. Kh. Azimova
Research Subjects
M. Kh. Azimova has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alexander I. Kostin
N.V. Sklifosovsky Research Institute of Emergency Medicine, Moscow Department of Healthcare
2 shared publications - Ali M. Gasanov
N.V. Sklifosovsky Research Institute for Emergency Medicine Bolshaya; Penza Institute of Advanced Medical Training – branch of the Russian Medical Academy of Continuous Professional Education
1 shared publication - Alina R. Kamalova
Sklifosovsky Emergency Medicine Research Institute
1 shared publication - Andrey Yu. Bulanov
N.V. Sklifosovsky Research Institute for Emergency Medicine, Moscow, Russia
1 shared publication - E. S. Makarova
Sklifosovsky Emergency Medicine Research Institute
1 shared publication - E. V. Yakovleva
National Medical Research Center for Hematology
1 shared publication
Latest Publications
- Open Access
- 10 July 2025
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 70 (2) , 165-173
The use of donor platelets in the hospital of emergency medicine
Introduction. A multidisciplinary emergency hospital is a significant consumer of platelet concentrates (PCs). The specificity of requirements, logistics, and clinical use of PCs in multidisciplinary hospitals may affect the strategy for procuring this blood component.Aim: to analyze the practice of PC transfusion in a multidisciplinary hospital providing emergency and urgent care to the population.Materials and methods. In a retrospective observational study spanning over a 5-year period, 7,049 PC transfusions were examined in an emergency care multidisciplinary hospital. The study analyzed the indications for PC transfusion, PC efficacy, transfusion load on the recipient, urgency of performing PC transfusion, group compatibility of used PCs, PC type, and compared the corrected count increment (CCI) 24 hours after transfusion of various PC types.Results. Between 23 % and 29 % of all PCs were transfused to patients who were admitted with polytrauma and massive blood loss, 18–27% were transfused to patients with septic complications, 8–13 % to patients during preparation and postoperative management for liver transplantation, 21 % to patients who underwent ECMO. Emergency indications accounted for 31.8–40.7% of PC transfusions. In 61.5 % of cases, the indication was hemorrhagic syndrome in combination with thrombocytopenia. AB0-identical transfusions were performed in 4,723 (67.1 %) cases. There were no significant differences in CCI when using apheresis, pooled or cryopreserved PCs.Conclusion. When planning the work of hospitals providing emergency medical care to patients with surgical and traumatological profiles, the need for PC transfusions in 1.5–2 % of patients should be considered. Emergency supply can be facilitated using the “platelet management” tools: a reserve of universal donor PCs-prepared in additive solution or obtained apheresis from AB-group donors or via pooling from O-group donorsand cryopreserved PCs.
- 10 July 2025
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 70 (2) , 165-173
Open AccessThe use of donor platelets in the hospital of emergency medicine
Introduction. A multidisciplinary emergency hospital is a significant consumer of platelet concentrates (PCs). The specificity of requirements, logistics, and clinical use of PCs in multidisciplinary hospitals may affect the strategy for procuring this blood component.Aim: to analyze the practice of PC transfusion in a multidisciplinary hospital providing emergency and urgent care to the population.Materials and methods. In a retrospective observational study spanning over a 5-year period, 7,049 PC transfusions were examined in an emergency care multidisciplinary hospital. The study analyzed the indications for PC transfusion, PC efficacy, transfusion load on the recipient, urgency of performing PC transfusion, group compatibility of used PCs, PC type, and compared the corrected count increment (CCI) 24 hours after transfusion of various PC types.Results. Between 23 % and 29 % of all PCs were transfused to patients who were admitted with polytrauma and massive blood loss, 18–27% were transfused to patients with septic complications, 8–13 % to patients during preparation and postoperative management for liver transplantation, 21 % to patients who underwent ECMO. Emergency indications accounted for 31.8–40.7% of PC transfusions. In 61.5 % of cases, the indication was hemorrhagic syndrome in combination with thrombocytopenia. AB0-identical transfusions were performed in 4,723 (67.1 %) cases. There were no significant differences in CCI when using apheresis, pooled or cryopreserved PCs.Conclusion. When planning the work of hospitals providing emergency medical care to patients with surgical and traumatological profiles, the need for PC transfusions in 1.5–2 % of patients should be considered. Emergency supply can be facilitated using the “platelet management” tools: a reserve of universal donor PCs-prepared in additive solution or obtained apheresis from AB-group donors or via pooling from O-group donorsand cryopreserved PCs.
- Open Access
- 18 May 2021
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 66 (1) , 79-87-87
Diagnosis and choice of haemostatic therapy during surgery in patients with combined coagulation factor V and VIII defi ciency
Introduction. Among the most common congenital coagulopathies are haemophilia and Von Willebrand disease. These illnesses are often mimicked by orphan hereditary coagulopathies, including combined coagulation factor V and VIII deficiency.Aim — description of a clinical presentation, hampered diagnosis and choice of haemostatic therapy in a surgical patient with combined blood coagulation factor V and VIII deficiency.Main findings. We describe a clinical case of congenital combined factor V and VIII deficiency and detail the aetiology, frequency, localisation and intensity of haemorrhages. Comorbidity and surgical indications are demonstrated to require an inter-specialty medical involvement.
- 18 May 2021
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 66 (1) , 79-87-87
Open AccessDiagnosis and choice of haemostatic therapy during surgery in patients with combined coagulation factor V and VIII defi ciency
Introduction. Among the most common congenital coagulopathies are haemophilia and Von Willebrand disease. These illnesses are often mimicked by orphan hereditary coagulopathies, including combined coagulation factor V and VIII deficiency.Aim — description of a clinical presentation, hampered diagnosis and choice of haemostatic therapy in a surgical patient with combined blood coagulation factor V and VIII deficiency.Main findings. We describe a clinical case of congenital combined factor V and VIII deficiency and detail the aetiology, frequency, localisation and intensity of haemorrhages. Comorbidity and surgical indications are demonstrated to require an inter-specialty medical involvement.